Bayer shares slump as US court approves review of Monsanto case.


Shares in Bayer slumped on Wednesday, after the Washington state Supreme Court said it would review a case alleging that exposure to products of the German chemicals company's Monsanto unit harmed three teachers.

  • Bayer AG
  • 09 October 2024 14:02:52

Source: Sharecast

The court said it accepted the case for review in a filing on its website, while also denying an application for a speedy review, Bloomberg reported.

Bayer shares fell more than 7% in Frankfurt on Wednesday. Monsanto persuaded an appeals court in Washington state to throw out a $185m jury award in May, after a three-judge panel found flaws in the 2021 trial over claims that Monsanto’s polychlorinated biphenyls, or PCBs, caused the illnesses to the Seattle-area educators.

The case was the first of more than half a dozen verdicts with combined damages of more than $1.5bn to reach the appeals court over alleged PCB exposure at the Sky Valley Education Center.

Bayer argues the claims relate to industrial materials which Monsanto voluntarily ended manufacture of in 1977. It bought the US agrichemical maker in 2018.

Reporting by Frank Prenesti for Sharecast.com


Exchange: Neuer Markt
Sell:
6,564.80
Buy:
6,564.80
Change: 257.89 ( 1.12 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.